Shenzhen Bioeasy Biotechnology Balance Sheet Health
Financial Health criteria checks 3/6
Shenzhen Bioeasy Biotechnology has a total shareholder equity of CN¥853.7M and total debt of CN¥409.6M, which brings its debt-to-equity ratio to 48%. Its total assets and total liabilities are CN¥1.4B and CN¥525.0M respectively.
Key information
48.0%
Debt to equity ratio
CN¥409.62m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥582.02m |
| Equity | CN¥853.72m |
| Total liabilities | CN¥525.04m |
| Total assets | CN¥1.38b |
Recent financial health updates
No updates
Recent updates
Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 28% Price Boost Is Out Of Tune With Revenues
Sep 30
Subdued Growth No Barrier To Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) Price
Jun 26Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Mar 08Financial Position Analysis
Short Term Liabilities: 300942's short term assets (CN¥733.3M) exceed its short term liabilities (CN¥141.7M).
Long Term Liabilities: 300942's short term assets (CN¥733.3M) exceed its long term liabilities (CN¥383.3M).
Debt to Equity History and Analysis
Debt Level: 300942 has more cash than its total debt.
Reducing Debt: 300942's debt to equity ratio has increased from 0% to 48% over the past 5 years.
Debt Coverage: 300942's debt is not well covered by operating cash flow (9.1%).
Interest Coverage: Insufficient data to determine if 300942's interest payments on its debt are well covered by EBIT.